Download PDF
Thromb Haemost 1977; 37(01): 123-135
DOI: 10.1055/s-0038-1649210
Original Article
Schattauer GmbH

The Reversible Antithrombin Activity of Incubated Plasma

E. D Gomperts
1   Department of Haematology, Royal Postgraduate Medical School, Ducane Road, London W12, England.
,
J. C Stavridis
1   Department of Haematology, Royal Postgraduate Medical School, Ducane Road, London W12, England.
,
R. S Mibashan
1   Department of Haematology, Royal Postgraduate Medical School, Ducane Road, London W12, England.
› Author Affiliations
Further Information

Publication History

Received 12 January 1976

Accepted 03 September 1976

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The thrombin time of normal citrated plasma is progressively prolonged on incubation in open glass tubes at 37° C. The phenomenon is dependent on the temperature and duration of incubation, on the pH, and on the concentration of calcium ions present. Platelet-rich citrated plasma fails to exhibit augmented antithrombin activity when similarly incubated, and the addition of washed platelets to platelet-poor plasma inhibits this activity. The clot retarding action of incubated plasma against thrombin is also manifested against Arvin (Ancrod), but not against Reptilase-R. This thrombin time lenghening may be inhibited by incubation with anti-antithrombin III antiserum thus indicating that the phenomenon of thrombin time lengthening is consistent with enhanced activity of antithrombin III. It is unlikely that alterations in the activity of α2-macroglobulin, is important in the reduced thrombin-coagulability of incubated plasma. Interference with the polymerisation of fibrin monomers by the physicochemical changes may contribute to the observed phenomenon.

 

  • References

  • 1 Abildgaard U. Inhibition of the thrombin fibrinogen reaction by antithrombin III. Studied by N-terminal analysis. Scandinavian Journal of Clinical and laboratory Investigation 1967; 20: 207
    CrossrefPubMedGoogle Scholar
  • 2 Banfi R.F, Tanturi C.A, Bay R. Prothrombin in preserved blood. Journal of Laboratory and Clinical Medicine 1945; 30: 512
    PubMedGoogle Scholar
  • 3 Barber A.J, Jamieson G.A. Isolation and characterisation of plasma membranes from human blood platelets. Journal of Biological Chemistry 1970; 245: 6357
    PubMedGoogle Scholar
  • 4 Blomback B, Blomback M, Nilsson I.M. Coagulation studies on reptilase, an extract of the venom from Bothrops jararaca. Thrombosis et Diathesis Haemorrhagica 1958; 1: 76
    PubMedGoogle Scholar
  • 5 Chan K.E, Rizza C.R, Henderson M.P. A study of the coagulant properties of Malayan Pit-viper venom. British Journal of Haematology 1965; 11: 646
    CrossrefPubMedGoogle Scholar
  • 6 Dacie J.V, Lewis S.M. Practical Haematology . J. & A. Churchill; London: 1970. p. 536 and p. 289
    Google Scholar
  • 7 Kloczewiak M, Wegrzynowicz Z, Matthias F.R, Heene D.L. Studies on chemically modified fibrinogen. Thrombosis and Haemostasis 1976; 35: 324
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Luscher E.F, Kaser-Glanzmann R. Platelet heparin neutralising factor (Platelet Factor 4). Thrombosis et Diathesis Haemorrhagica 1974; 33: 66
    PubMedGoogle Scholar
  • 9 Nilsson I.M, Wenckert A. Demonstrations of heparin like anticoagulant in normal blood. Acta Medica Scandinavica suppl 1954; 297
    PubMedGoogle Scholar
  • 10 Owen C.A, Bowie E.J.W, Didisheim P, Thompson J.H. The diagnosis of bleeding disorders . Littler, Brown & Co; Boston: 1969: p. 75
    Google Scholar
  • 11 Pitney W.R, Regoeczi E. Investigation of Arvin by plasma proteins. British Journal of Haematology 1970; 19: 67
    CrossrefPubMedGoogle Scholar
  • 12 Ratnoff O.D, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 1951; 37: 316
    PubMedGoogle Scholar
  • 13 Ratnoff O.D. An accelerating property of plasma for the coagulation of fibrinogen by thrombin. Journal of Clinical Investigation 1954; 33: 1175
    CrossrefPubMedGoogle Scholar
  • 14 Regoeczi E, Gergely J, McFarlane A.S. In vivo effects of Agkistrodon rhodostoma venom. Studies with Fibrinogen 131I. Journal of Clinical Investigation 1966; 45: 1202
    CrossrefPubMedGoogle Scholar
  • 15 Stefanini M. Antithrombin activity of stored plasma. American Journal of Clinical Pathology 1948; 18: 537
    CrossrefPubMedGoogle Scholar
  • 16 Stormorken H. Reactivity of stored plasma to thrombin, with reference to the fibrinogen conversion acceleration and heparinoid activity. British Journal of Haematology 1957; 3: 299
    CrossrefPubMedGoogle Scholar
  • 17 Tanturi C.A, Wetzel N.C. Studies upon the relation between plasma antithrombin and heparin. I. The influence of plasma antithrombin on prothrombin time. American Journal of Medical Science 1949; 217: 410
    CrossrefPubMedGoogle Scholar
  • 18 Tocantins L.M. Loss of prothrombin activity in plasma exposed to air currents. Proceedings of the Society of Experimental Biology Medicine 1942; 49: 251
    PubMedGoogle Scholar
  • 19 Triantaphyllopoulos D.C, Quick A.J, Greenwalt T.J. Action of disodium ethylenediamine tetracetate on blood coagulation. Blood 1955; 10: 534
    PubMedGoogle Scholar
  • 20 Vermyelen C, De Vreker R.A, Vestraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time. Clínica Chimica Acta 1963; 8: 418
    PubMedGoogle Scholar
  • 21 Walsh P.N, Gagnatelli G. Platelet antiheparin activity. Storage site and release mechanism. Blood 1974; 44: 157
    PubMedGoogle Scholar